- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Enanta Pharmaceuticals Inc+ Add to Watchlist
ENTA:US33.3900 USD 0.2600 0.78%
As of 20:10:00 ET on 04/17/2014.
Company Profile for Enanta Pharmaceuticals Inc (ENTA)
Enanta Pharmaceuticals Inc. manufactures pharmaceutical products. The Company develops, produces, and markets antibacterial drugs for hepatitis C virus, respiratory tract infections, intravenous, and oral treatments for hospital and community. Enanta Pharmaceuticals offers its products throughout the United States.
Enanta Pharmaceuticals Inc
Key Executives for Enanta Pharmaceuticals Inc (ENTA)
|Jay R LulyPresident/CEO||Paul J MellettSenior VP:Finance/CFO|
|Timothy D OcainSenior VP:New Product Strategy||Yat Sun OrSenior VP:R&D/CSO|
|Carol MiceliDirector:Investor Relations|